Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05794854
Other study ID # MUCSR12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2005
Est. completion date May 2006

Study information

Verified date March 2023
Source Molde University College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Spot reduction, referring to local body fat reduction, pertains to subcutaneous adipose tissue utilization from specific body parts during exercise. Its existence has been keenly debated, although generally accepted not to occur during exercise. However, it is based on not only equivocal data - commonly the training protocol typically applied is based on strength rather than endurance training. The investigators sought to test this assumption by utilizing endurance based exercise controlling for energy expenditure and using dual x-ray absorptiometric measures to assess body composition before and after training.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date May 2006
Est. primary completion date May 2006
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - males - = 30 years old - classified as overweight (Body mass index = 25 kg · m-2) - not participating in regular physical training Exclusion Criteria: - < 30 years old - Body mass index < 25 kg · m-2 - participating in regular physical training

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Abdominal aerobic endurance exercise
Subjects combined treadmill running at 70% HRmax (27 minutes) with 4x4minutes (30-40% maximal strength, 1RM) of torso rotation and abdominal crunches (57 minutes), 4 days per wk for 10 weeks
Control training intervention
Subjects performed treadmill running (45 minutes) at 70% HRmax 4 days per week for 10 weeks

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Molde University College Norwegian University of Science and Technology

Outcome

Type Measure Description Time frame Safety issue
Other Trunk lean mass change Lean mass located in trunk (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Other Lower extremity lean mass change Lean mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Other Upper extremity lean mass change Lean mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Other Total lean mass change Total lean mass (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Other Maximal oxygen uptake change Maximal oxygen uptake by cardiopulmonary indirect calorimetry Change from pre (baseline) to post test (after 10 weeks)
Other Maximal muscle strength change One-repetition maximum (kg) in torso rotation and abdominal crunch Change from pre (baseline) to post test (after 10 weeks)
Primary Trunk fat mass change Fat mass located in trunk (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Secondary Lower extremity fat mass change Fat mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Secondary Upper extremity fat mass change Fat mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Secondary Total fat mass change Total fat mass (g) measured by dual-energy x-ray absorptiometry Change from pre (baseline) to post test (after 10 weeks)
Secondary Body weight change Change from pre (baseline) to post test (after 10 weeks)
Secondary Body mass index change Change from pre (baseline) to post test (after 10 weeks)
Secondary Waist circumference (cm) change Change from pre (baseline) to post test (after 10 weeks)
Secondary Hip circumference (cm) change Change from pre (baseline) to post test (after 10 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1